Publication
International arbitration report
In this edition, we focused on the Shanghai International Economic and Trade Arbitration Commission’s (SHIAC) new arbitration rules, which take effect January 1, 2024.
Healthcare Regulation 2024
Getting the Deal Through, Lexology
Authors:
United States | Publication | November 2023
Healthcare in America is big business. With annual expenditures in 2021 topping US$4.5 trillion, healthcare spending consumes 18.3 percent of the US gross domestic product. More than half of personal healthcare expenditures in the US are subsidized financially by the public sector, which makes government a key policy actor.
Susan Feigin Harris, Elise LeGros, Kathleen Rubinstein (Houston), Jeff Wurzburg (San Antonio/Washington, DC) and David Aplington (St. Louis), with Stacey Murphy (St. Louis), Mark Faccenda (Washington, DC), Denise Webb Glass, Jennifer Ann McDaniel (Dallas), Susan Linda Ross and Gerald A. Stein (New York) address a multitude of laws and regulations governing the US healthcare industry in their Lexology article, "Getting the Deal Through: Healthcare Regulation 2024."
Co-Head of Healthcare, United States
Email
susan.harris@nortonrosefulbright.com
Co-Head of Healthcare, United States Partner-in-Charge, Denver and St. Louis
Email
stacey.murphy@nortonrosefulbright.com
Office Administrative Partner, Dallas
Email
denise.glass@nortonrosefulbright.com
Senior Counsel
Email
jennifer.mcdaniel@nortonrosefulbright.com
Senior Counsel
Email
susan.ross@nortonrosefulbright.com
Senior Analyst, Health Care
Email
kathleen.rubinstein@nortonrosefulbright.com
Recent publications
Publication
Road to COP29: Our insights
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Publication
The GCR Guide to Life Sciences – Merger control: Procedural issues
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .